Total Payments
$13,868
2024 Payments
$2,079
Companies
59
Transactions
1,000
Medicare Patients
4,564
Medicare Billing
$262,687
Payment Breakdown by Category
Food & Beverage$13,813 (99.6%)
Education$54.46 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,813 | 992 | 99.6% |
| Education | $54.46 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,137 | 174 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,433 | 106 | $0 (2024) |
| Amgen Inc. | $1,251 | 88 | $0 (2024) |
| Lilly USA, LLC | $1,186 | 103 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $981.23 | 46 | $0 (2024) |
| PFIZER INC. | $954.13 | 86 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $412.42 | 32 | $0 (2022) |
| Novo Nordisk Inc | $412.35 | 30 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $394.92 | 26 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $378.66 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,079 | 143 | ABBVIE INC. ($424.93) |
| 2023 | $2,366 | 161 | ABBVIE INC. ($520.30) |
| 2022 | $2,266 | 162 | ABBVIE INC. ($371.49) |
| 2021 | $2,142 | 170 | AbbVie Inc. ($479.16) |
| 2020 | $1,448 | 111 | GlaxoSmithKline, LLC. ($192.78) |
| 2019 | $1,419 | 119 | PFIZER INC. ($174.77) |
| 2018 | $1,790 | 115 | Novartis Pharmaceuticals Corporation ($203.33) |
| 2017 | $357.43 | 19 | Janssen Pharmaceuticals, Inc ($111.12) |
All Payment Transactions
1,000 individual payment records from CMS Open Payments — Page 2 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Respiratory | ||||||
| 08/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardio-renal | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Biological | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: PAIN | ||||||
| 08/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Diabetes Care | ||||||
| 07/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Inflammation | ||||||
| 07/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,215 | 1,928 | $201,301 | $66,257 |
| 2022 | 21 | 1,033 | 1,723 | $158,021 | $53,558 |
| 2021 | 23 | 1,178 | 1,837 | $182,918 | $65,573 |
| 2020 | 19 | 1,138 | 1,797 | $169,677 | $77,298 |
Total Patients
4,564
Total Services
7,285
Medicare Billing
$262,687
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 709 | $105,641 | $31,593 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 155 | 155 | $28,830 | $7,742 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 137 | $13,856 | $5,262 | 38.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 63 | 63 | $5,094 | $4,776 | 93.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 50 | 50 | $13,800 | $4,540 | 32.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,425 | $2,022 | 45.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 39 | 40 | $6,040 | $1,922 | 31.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 65 | $2,600 | $1,809 | 69.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 15 | $4,770 | $1,402 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,497 | $939.67 | 37.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 43 | $2,119 | $885.85 | 41.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 71 | 91 | $3,640 | $837.76 | 23.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 53 | 53 | $1,537 | $762.93 | 49.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,639 | $640.72 | 39.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 46 | $1,840 | $348.75 | 19.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $440.00 | $306.13 | 69.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $374.00 | $178.20 | 47.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 45 | 62 | $403.00 | $136.40 | 33.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $648.00 | $102.10 | 15.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 48 | $548.00 | $30.47 | 5.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 26 | 280 | $560.00 | $20.55 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 321 | 537 | $80,013 | $24,374 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 284 | $28,684 | $11,126 | 38.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 47 | 49 | $3,790 | $3,431 | 90.5% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $3,312 | $2,982 | 90.0% |
About Dr. Benjamin Mcdonald, D.O
Dr. Benjamin Mcdonald, D.O is a Family Medicine healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1184935827.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Mcdonald, D.O has received a total of $13,868 in payments from pharmaceutical and medical device companies, with $2,079 received in 2024. These payments were reported across 1,000 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($13,813).
As a Medicare-enrolled provider, Mcdonald has provided services to 4,564 Medicare beneficiaries, totaling 7,285 services with total Medicare billing of $262,687. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Little Rock, AR
- Active Since 06/28/2010
- Last Updated 10/02/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184935827
Products in Payments
- TRELEGY ELLIPTA (Drug) $919.83
- VRAYLAR (Drug) $779.35
- UBRELVY (Drug) $591.30
- EMGALITY (Drug) $571.05
- NURTEC ODT (Drug) $566.68
- Aimovig (Biological) $439.25
- Livalo (Drug) $412.42
- FARXIGA (Drug) $406.04
- QULIPTA (Drug) $334.05
- JARDIANCE (Drug) $318.35
- Otezla (Drug) $306.89
- BREZTRI (Drug) $262.45
- ENTRESTO (Drug) $260.37
- Synthroid (Drug) $234.04
- XARELTO (Drug) $215.48
- EVENITY (Biological) $212.34
- SHINGRIX (Biological) $206.34
- MOUNJARO (Drug) $191.42
- Kerendia (Drug) $185.13
- Auvelity (Drug) $171.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Little Rock
Dr. Kevin Roberts, Md, MD
Family Medicine — Payments: $133,330
Family Medicine $133,330
Dr. Derek Lewis, M.d, M.D
Family Medicine — Payments: $117,470
Family Medicine $117,470
Dr. Harold Betton, M.d, M.D
Family Medicine — Payments: $23,468
Family Medicine $23,468
Dr. Oksana Melnyk, M.d, M.D
Family Medicine — Payments: $14,185
Family Medicine $14,185
Dr. J . Timothy Hodges, Md, MD
Family Medicine — Payments: $13,633
Family Medicine $13,633
Dr. Thomas Moore, Md, MD
Family Medicine — Payments: $13,080
Family Medicine $13,080